Company profile
Lakefront Biotherapeutics NV
Immunology (biotech)
LKFT · NASDAQ (Formerly Galapagos NV (GLPG); renamed Lakefront Biotherapeutics NV effective 2026-05-08, same legal entity and SEC registrant (CIK 1421876). Verified against SEC company_tickers.json, which lists LKFT and no longer lists GLPG. The old glpg.com domain no longer resolves.) · Belgium
Share price · LKFT
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Unadjusted for historical splits · Data via Databento
Assets
(1 total)
| Target & Modality | |||
|---|---|---|---|
GLPG1690No recent activity | Phase 3 | Undisclosed / early pipeline | Indication not yet linked |
Upcoming events
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.
Insider transactions
Unlock insider transactions
Research includes SEC Form 4 insider transactions — filed buys, sells, awards and exercises linked to the underlying filings.
Institutional holders
Unlock institutional holders
Research includes quarterly SEC 13F institutional ownership — top holders, aggregate positions and quarter-over-quarter context.